RCM
EVH icon

RA Capital Management’s Evolent Health EVH Stock Holding History

RA Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-579,052
Closed -$4.9M – 75
2025
Q3 		$4.9M Buy
+579,052
New +$5.62M 0.06% 62
2025
Q1 		– Sell
-3,577,197
Closed -$40.2M – 91
2024
Q4 		$40.2M Sell
3,577,197
-4,937,665
-58% -$86.8M 0.54% 40
2024
Q3 		$241M Hold
8,514,862
– – 2.78% 8
2024
Q2 		$163M Buy
8,514,862
+2,778,730
+48% +$71M 2.15% 14
2024
Q1 		$188M Buy
5,736,132
+3,187,000
+125% +$102M 2.39% 7
2023
Q4 		$84.2M Sell
2,549,132
-187,548
-7% -$5.31M 1.32% 23
2023
Q3 		$74.5M Buy
+2,736,680
New +$76.1M 1.47% 20

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RA Capital Management's EVH Position: Q4 2025 in Review

RA Capital Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 579,052 shares — an estimated $4.9M sold.

RA Capital Management first reported a position in EVH in Q3 2023 and held it in 7 quarters. The position peaked at $241M in Q3 2024. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • RA Capital Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • RA Capital Management sold 579,052 Evolent Health shares in Q4 2025, an estimated $4.9M.
  • RA Capital Management first reported a position in Evolent Health in Q3 2023 and held it in 7 quarters.
  • RA Capital Management's Evolent Health position peaked at $241M in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on RA Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.